Gastro Medical News about Crohn's Disease

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
BMC Gastroenterology, 09/14/09

Miheller P et al. – IFX was safe and effective treatment in this cohort of Hungarian CD patients. Based on experience co–administration of immunosuppressant therapy is suggested in patients receiving IFX induction therapy. However, concomitant steroid treatment did not influence the efficacy of IFX induction therapy.

<< Previous
Solar Drinking Water Disinfection (SODIS) to Reduce Childhood...

Next >>
Hepatitis C Infection and Related Factors in Hemodialysis...

A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09 Relevance Score: 69%

Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09 Relevance Score: 68%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09 Relevance Score: 68%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09 Relevance Score: 68%

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09 Relevance Score: 68%